Does ROXITHROMYCIN Cause Bladder transitional cell carcinoma? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Bladder transitional cell carcinoma have been filed in association with ROXITHROMYCIN. This represents 6.5% of all adverse event reports for ROXITHROMYCIN.
23
Reports of Bladder transitional cell carcinoma with ROXITHROMYCIN
6.5%
of all ROXITHROMYCIN reports
0
Deaths
23
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From ROXITHROMYCIN?
Of the 23 reports, 23 (100.0%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROXITHROMYCIN. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does ROXITHROMYCIN Cause?
Diarrhoea (30)
Nausea (28)
Erythema (26)
Arthralgia (24)
Headache (20)
Jaundice (18)
Palpitations (18)
Abdominal pain upper (17)
Asthenia (17)
Vomiting (17)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which ROXITHROMYCIN Alternatives Have Lower Bladder transitional cell carcinoma Risk?
ROXITHROMYCIN vs ROZANOLIXIZUMAB
ROXITHROMYCIN vs ROZANOLIXIZUMAB-NOLI
ROXITHROMYCIN vs RUBIDIUM RB-82
ROXITHROMYCIN vs RUCAPARIB
ROXITHROMYCIN vs RUCAPARIB CAMSYLATE